TCL Archive Progression-free survival as a primary endpoint for drug approval requires prospective planning, FDA’s Pazdur says. May 7, 2004
TCL Archive In Brief: Huntsman Cancer Institute Joins NCCN: Howard cancer Center To Honor Mandela November 7, 1997
TCL Archive Congress Provides 7% Increase For NIH, 6.6% for NCI, In FY98 Appropriation November 14, 1997
